Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163096 · ClinicalTrials.gov registry record
A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma
A clinical trial of Asthma and Wheezing, sponsored by University of Louisville.
- Completed
- Registry status
- 23
- Enrollment target
- 3
- Study locations
NCT02163096 is a study of Asthma and Wheezing that has completed, run by University of Louisville. The registered enrollment target is 23 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT02163096, a study of Asthma and Wheezing, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to assess benign joint hypermobility syndrome (BJHS) in children with a history of wheezing or asthma. BJHS is a common syndrome of joint and connective tissue laxity without any other rheumatologic disease. This assessment will be performed by using either method below depending upon if the child has a history of wheezing or severe asthma: 1. Determine the correlation, if there is an increased rate of BJHS in children with a history of wheezing as well as if there is an increased history of wheezing in children with BJHS; or 2. Determine asthma control, lung function and asthma exacerbations (a flare up or acute worsening of symptoms) in children with BJHS compared to children with asthma without BJHS, to assess if it BJHS is associated more with children with severe asthma.
Conditions Studied
Study Locations (3)
Kentucky
- University of Louisville - Sam Swope Kosair Charities Centre - Louisville
- University of Louisville Allergy and Immunology - Louisville
- University of Louisville Pediatric Pulmonology - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163096
The ClinicalTrials.gov registry entry for NCT02163096 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT02163096 reports 3 study locations spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT02163096 about?
NCT02163096 is a clinical study titled "A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma". The purpose of this study is to assess benign joint hypermobility syndrome (BJHS) in children with a history of wheezing or asthma. BJHS is a common syndrome of joint and connective tissue laxity without any other rheumatologic disease. This assessment will be performed by using either method below ...
What is the current status of trial NCT02163096?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2014-06. Estimated completion is 2015-06.
What conditions does trial NCT02163096 study?
This clinical trial studies the following conditions: Asthma, Wheezing, Benign Joint Hypermobility Syndrome.
Who is sponsoring clinical trial NCT02163096?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02163096 being conducted?
This trial has 3 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.